Skip to content
The Nexus
DossierENTITY

Lantus Solostar

Coverage of Lantus Solostar in the Nexus archive.

Earliest in view: Jul 23 · 16:23 UTCMost recent: Jul 23 · 16:23 UTC
Co-mentioned in this coverage
Sanofiorganization1Food and Drug Administrationorganization1insulin glarginetopic1diabetestopic1
Recent coverage
  • HEALTHJul 23 · 16:23 UTCSTAT NEWS
    STAT+: Popular insulin product enters shortage as other pens leave market

    Sanofi's Lantus Solostar insulin pen is experiencing supply issues due to increased demand, causing patients to struggle to find medication. The FDA does not classify the situation as a shortage, but Sanofi is accelerating production to address the problem.

Lantus Solostar · Dossier · The Nexus